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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Iowa News 
• Department Efforts 
• Opioid News 
 
Iowa News 
 
House File 2377: Approved by the Senate 
 
House File 2377 was approved by the Senate on April 30, 2018.  The legislation will now return 
to the House for a final vote, and then be delivered to Governor Reynold’s office for signature.  
As it stands now, the bill aligns with the Governor’s outlined priorities to combat opioid use 
problems in Iowa.     
 
The changes that will happen in Iowa if the bill is voted through and signed, will significantly 
improve the rating given to the state as outlined in the Opioid Initiatives Report Card developed 
by IDPH last October for the Legislative Opioid Study Committee.  More importantly, those 
changes will improve the lives of Iowans struggling with opioid use.       
 
 
() Indicates changes as a result of House File 2377.     
 
State of Iowa  
Opioid Initiatives Report Card     
Measure Yes No 
1. State has a Prescription Monitoring Program    
2. Prescribers are required to use the Prescription Monitoring Program  ()  
3. Prescription Monitoring Program has 24-hour upload from pharmacies ()  
4. State utilizes prescription limits for opioids  X 
5. State has a Syringe Services Program  X 
6. State has a Good Samaritan Law ()  
7. State has Expanded Naloxone Access    
8. State has dedicated funding for Naloxone  X 
9. State has Medicaid coverage for all forms of medication assisted treatment    
10. State requires training on CDC Guidelines for Managing Chronic Pain ()  
 
Department Efforts 
 
IDPH Staff Working to Educate  
Others on Opioid Misuse 
 
In addition to efforts such as the bi-weekly Opioid 
Update and ongoing media campaigns, IDPH staff 
have been actively working to educate others 
regarding Iowa’s experience with the nationwide 
opioid crisis.  In April, staff presented at the Iowa 
Public Health Conference, the 41st Annual 
Governor’s Conference on Substance Abuse 
(pictured: Monica Wilke-Brown and Jennifer 
Robertson-Hill), and the annual Sioux City Police 
Department’s Town Hall meeting.    
 
As part of its coordinating efforts across multiple federal grants – Preventing Opioid Misuse 
amongst Women (POMW), State Targeted Response (STR), Medication Assisted 
Treatment – Prescription Drug and Opioid Addiction (MAT-PDOA), Strategic Prevention 
Framework for Prescription Drugs (SPF-Rx), and AmeriCorps Substance Abuse 
Prevention Program – IDPH has been broadly disseminating information on a range of opioid 
related topics, such as: overview of the opioid epidemic; addressing the opioid issue in Iowa; 
medication-assisted treatment; and overdose recognition and response.  
 
For more information on upcoming presentations, or to request that IDPH staff speak to your 
group or community, please contact Kevin Gabbert at kevin.gabbert@idph.iowa.gov.   
 
Opioid News 
 
USDA Resources Available to Support Communities Dealing with Opioids 
 
The USDA recently announced two Rural Development funding opportunities available to rural 
communities: 
 
• Community Facilities Program Grants:  The USDA reserved $5 million in grants for 
innovative projects that address the opioid crisis in rural America. Communities, 
nonprofit organizations, and federally recognized tribes can apply for up to $150,000 in 
grants for innovative projects, such as mobile treatment clinics. The grants can be used 
to fund up to 75 percent of a project’s cost.   
 
• Distance Learning and Telemedicine Grants:  The USDA will give priority to applications 
for projects to provide opioid misuse prevention, treatment, or recovery services.  
Congress has set aside $20 million for Distance Learning and Telemedicine grants 
specifically for opioid prevention, treatment and recovery projects. Eligible proposals can 
receive 10 priority points.   
 
Applications are due June 4, 2018.   
 
In addition to these funding opportunities, Rural Development’s Innovation Center is working to 
promote strategic partnerships and local capacity building, identify and share best practices, 
evaluate data, and streamline regulations to remove barriers to rural prosperity, including 
access to mental and behavioral health care. 
 
For more information on USDA funding opportunities and efforts in addressing Opioid Misuse in 
Rural America, please visit the following website: USDA  
 
More than 4 million people left the workforce because of opioid addiction 
 
According to a study by the American Action Forum, from 1999 to 2015, there were 4.1 million 
fewer people in the workforce because of opioid addiction, the latest research to show that drug 
use is having a profound effect on the U.S. economy. 
 
The study finds that the loss of these employees, ages 25 to 54, and their productivity cost the 
U.S. economy $702.1 billion, or just under $44 billion per year.  The number of people who are 
not working because they are dependent on opioids has grown each year since 1999. Nearly 1 
million people in their prime earning years were absent from the workforce in 2015 because of 
opioid addiction, according to the study. 
 
To read the entire article, please click on the following link: Chicago Tribune 
 
New Opioid Training for Primary Care Providers: Assessing and Addressing 
Opioid Use Disorder 
 
The Centers for Disease Control and Prevention (CDC) launched Assessing and Addressing 
Opioid Use Disorder, the fifth module in a series of interactive, online trainings for healthcare 
providers. Participants will look at how opioid use disorder (OUD) is diagnosed using the 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) assessment 
criteria, and learn how to discuss this diagnosis with patients. Providers will also examine the 
different types of medications used for medication-assisted therapy (MAT). This training 
features recommendations from the CDC Guideline for Prescribing Opioids for Chronic Pain and 
resources from SAMHSA, and provides sample scenarios and clinical tools and resources. 
 
To learn more about this training opportunity, please click on the following link: CDC 
